IMC Chicago
CLPT icon

IMC Chicago’s ClearPoint Neuro CLPT Stock Holding History

IMC Chicago’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
89,800
+25,200
+39% +$315K ﹤0.01% 3302
2026
Q1 		$588K Sell
64,600
-19,700
-23% -$249K ﹤0.01% 3860
2025
Q4 		$1.15M Buy
84,300
+33,800
+67% +$627K ﹤0.01% 2865
2025
Q3 		$1.1M Buy
+50,500
New +$595K ﹤0.01% 2643

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

IMC Chicago's CLPT Position: Q2 2026 in Review

IMC Chicago reduced its ClearPoint Neuro (CLPT) stake by 44% in Q2 2026, selling an estimated $263K and leaving 26,494 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #4713.

IMC Chicago first reported a position in CLPT in Q1 2026 and has held it in 2 quarters since. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • IMC Chicago held 26,494 shares of ClearPoint Neuro worth $473K as of Q2 2026.
  • IMC Chicago sold 21,049 ClearPoint Neuro shares in Q2 2026, an estimated $263K.
  • ClearPoint Neuro made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4713 holding.
  • IMC Chicago first reported a position in ClearPoint Neuro in Q1 2026 and has held it in 2 quarters since.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.